Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT06960096
- Status
- Recruiting
Conditions
- Deep Brain Stimulation
- Parkinson Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- DBS combined with fMRI — OTHERParticipants will undergo fMRI scanning while their DBS device is either turned OFF or ON. BOLD (blood oxygen level dependent) changes in response to DBS will be evaluated across PD participants. These scans and DBS procedure will be used for research purposes only and are not for treatment or diagnostic purposes.
Study Details
The objective of this research study is to understand how Deep Brain Stimulation (DBS) targeting the subthalamic nucleus (STN) affects cognitive networks in the brain, potentially leading to cognitive decline in patients with Parkinson's Disease (PD). A total of 55 participants with PD who have undergone DBS surgery will be recruited from MUSC's Clinical DBS Program. Participants will attend two post-DBS visits: a 3-hour visit for consent, demographic, and cognitive assessments, and a 3-hour DBS-MRI visit to evaluate brain network connectivity with stimulation ON and OFF. These findings will help improve patient selection for surgery and optimize the selection of stimulation targets that minimize undesirable cognitive side effects.
Key Dates
- Start date
- Aug 21, 2025
- Status verified
- Oct 2025
- Primary completion
- Apr 1, 2028
- Completion
- Apr 1, 2028
Study Design
- Enrollment
- 55 participants (estimated)
Arms
- Arm: Patients with Parkinson's Disease undergoing DBS
Primary Outcome Measure
Change in executive function performance [ Time Frame: Baseline and approximately 1 year (10-14 months) following deep brain stimulation ]
Central Contacts
- Recruitment Coordinator843-792-0235
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 |
Find similar trials in Charleston, SC
Related Studies
- Cognitive Decline Following Deep Brain StimulationRecruiting · Medical University of South Carolina · Charleston, South Carolina
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePHASE2 · Recruiting · Neuron23 Inc. · Sun City, Arizona
- Black and African Americans Connections to Parkinson's Disease (BLAAC PD)Recruiting · Michael J. Fox Foundation for Parkinson's Research · Birmingham, Alabama
- Imaging Biomarkers of FOG Response to DBSPHASE4 · Recruiting · Medical University of South Carolina · Charleston, South Carolina